HAEMORRHAGIC URTICARIA

HAEMORRHAGIC URTICARIA was reported 40 times

HAEMORRHAGIC URTICARIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
1 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 2 0.0000
2 Androgen [EPC] 1 0.0000
3 Iron Chelator [EPC] 1 0.0000
4 Provitamin D2 Compound [EPC] 1 0.0000
5 Interleukin-17A Antagonist [EPC] 1 0.0000
6 Integrin Receptor Antagonist [EPC] 2 0.0000
7 Muscle Relaxant [EPC] 1 0.0000
8 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
9 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
10 Angiotensin Converting Enzyme Inhibitor [EPC] 2 0.0000
11 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
12 Anti-IgE [EPC] 1 0.0000
13 Central Nervous System Stimulant [EPC] 1 0.0000
14 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
15 Expectorant [EPC] 2 0.0000
16 Anti-epileptic Agent [EPC] 2 0.0000
17 Fluoroquinolone Antibacterial [EPC] 1 0.0000
18 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
19 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
20 Kinase Inhibitor [EPC] 4 0.0000
21 Selective T Cell Costimulation Modulator [EPC] 1 0.0000
22 alpha-Adrenergic Blocker [EPC] 1 0.0000
23 Aldosterone Antagonist [EPC] 1 0.0000
24 Azole Antifungal [EPC] 1 0.0000
25 Janus Kinase Inhibitor [EPC] 1 0.0000
26 Corticosteroid [EPC] 6 0.0000
27 Mood Stabilizer [EPC] 1 0.0000
28 Thalidomide Analog [EPC] 2 0.0000
29 Opioid Agonist [EPC] 1 0.0000
30 Platinum-based Drug [EPC] 1 0.0000
31 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
32 Osmotic Laxative [EPC] 1 0.0000
33 beta-Adrenergic Blocker [EPC] 1 0.0000
34 Benzodiazepine [EPC] 2 0.0000
35 GLP-1 Receptor Agonist [EPC] 1 0.0000
36 Insulin Analog [EPC] 1 0.0000
37 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
38 Platelet Aggregation Inhibitor [EPC] 1 0.0000
39 Proton Pump Inhibitor [EPC] 1 0.0000
40 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
41 Tumor Necrosis Factor Blocker [EPC] 1 0.0000